Figure 1 | Scientific Reports

Figure 1

From: A novel Alzheimer’s disease prognostic signature: identification and analysis of glutamine metabolism genes in immunogenicity and immunotherapy efficacy

Figure 1

Framework. The data of AD patients were obtained from GEO databases, and then the GlnMgs were matched to carry out difference analysis and risk model construction, respectively.a˘GSE132903 was used as the main body and GSE63060 was used to verify the model with good grouping, and GlnMgs related to the prognosis of AD patients were obtained.a˘Then, GO, KEGG and GSEA analyses were performed with multiple databases to obtain the functions related to GlnMgs.a˘Last, the immune cells, function and RNA changesa˘were analyzed.

Back to article page